Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Huub J. van Eyk"'
Autor:
Lushun Yuan, Aswin Verhoeven, Niek Blomberg, Huub J. van Eyk, Maurice B. Bizino, Patrick C. N. Rensen, Ingrid M. Jazet, Hildo J. Lamb, Ton J. Rabelink, Martin Giera, Bernard M. van den Berg
Publikováno v:
Metabolites, Vol 14, Iss 1, p 33 (2024)
Type 2 diabetes mellitus (T2DM) poses a higher risk for complications in South Asian individuals compared to other ethnic groups. To shed light on potential mediating factors, we investigated lipidomic changes in plasma of Dutch South Asians (DSA) an
Externí odkaz:
https://doaj.org/article/ad85c4ff28364256bcca523ac38df8bc
Autor:
Elisabeth H. M. Paiman, Huub J. van Eyk, Maurice B. Bizino, Ilona A. Dekkers, Paul de Heer, Johannes W. A. Smit, Ingrid M. Jazet, Hildo J. Lamb
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-14 (2019)
Abstract Background The pathogenesis and cardiovascular impact of type 2 diabetes (T2D) may be different in South Asians compared with other ethnic groups. The phenotypic characterization of diabetic cardiomyopathy remains debated and little is known
Externí odkaz:
https://doaj.org/article/f427319a26f5406aab8e5a025896d0f0
Autor:
Huub J. van Eyk, Elisabeth H. M. Paiman, Maurice B. Bizino, Paul de Heer, Petronella H. Geelhoed-Duijvestijn, Aan V. Kharagjitsingh, Johannes W. A. Smit, Hildo J. Lamb, Patrick C. N. Rensen, Ingrid M. Jazet
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-12 (2019)
Abstract Background South Asians have a high risk to develop type 2 diabetes, which may be related to substantial ectopic fat deposition. Since glucagon-like peptide-1 analogues can reduce ectopic fat accumulation, the aim of the present study was to
Externí odkaz:
https://doaj.org/article/8192e95d0a7f403ab3e6c270721e4b7a
Autor:
Maurice B. Bizino, Ingrid M. Jazet, Jos J. M. Westenberg, Huub J. van Eyk, Elisabeth H. M. Paiman, Jan W. A. Smit, Hildebrandus J. Lamb
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-12 (2019)
Abstract Background Liraglutide is an antidiabetic agent with cardioprotective effect. The purpose of this study is to test efficacy of liraglutide to improve diabetic cardiomyopathy in patients with diabetes mellitus type 2 (DM2) without cardiovascu
Externí odkaz:
https://doaj.org/article/b482c0f383e847579de1263154683d09
Autor:
Maurice B. Bizino, Ingrid M. Jazet, Jos J. M. Westenberg, Huub J. van Eyk, Elisabeth H. M. Paiman, Jan W. A. Smit, Hildebrandus J. Lamb
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-2 (2019)
Following publication of the original article [1], the authors reported an error in Fig. 3. The bars in the upper right panel that represent heart rate in placebo treated patients is not correct.
Externí odkaz:
https://doaj.org/article/0ea1924b7f2e407785d900b7b79fea80
Autor:
Lushun Yuan, Ruifang Li‐Gao, Aswin Verhoeven, Huub J. van Eyk, Maurice B. Bizino, Patrick C. N. Rensen, Martin Giera, Ingrid M. Jazet, Hildo J. Lamb, Ton J. Rabelink, Bernard M. van den Berg
Publikováno v:
Diabetes, Obesity and Metabolism.
Autor:
Lushun Yuan, Ruifang Li-Gao, Aswin Verhoeven, Huub J. van Eyk, Maurice B. Bizino, Patrick C.N. Rensen, Martin Giera, Ingrid M. Jazet, Hildo J. Lamb, Ton J. Rabelink, Bernard M. Berg
Background: Composition of high-density lipoproteins (HDL) is emerging as an important determinant in the development of microvascular complications in type 2 diabetes mellitus (T2DM). Dutch South Asian (DSA) individuals with T2DM display an increase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de0d0e60d688cb9f95036facd4f5187a
https://doi.org/10.21203/rs.3.rs-2345386/v1
https://doi.org/10.21203/rs.3.rs-2345386/v1
Autor:
Ingrid M. Jazet, Huub J. van Eyk, Petronella H Geelhoed-Duijvestijn, Aan V. Kharagjitsingh, Maurice B. Bizino, Elisabeth H.M. Paiman, H.J. Lamb, Patrick C.N. Rensen, Johannes W. A. Smit
Aims: Data on the effect of liraglutide on glycemic endpoints in people with T2DM using multiple daily insulin injections (MDI) are scarce, especially in the context of ethnicity. Methods: This is a secondary analysis of the placebo-controlled random
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b3beed3f54d9a71cf5368bb2dc6c015
https://doi.org/10.1007/s00592-020-01635-0
https://doi.org/10.1007/s00592-020-01635-0
Autor:
Lisanne L. Blauw, Yanan Wang, Huub J. van Eyk, Renée de Mutsert, Johannes W. A. Smit, Patrick C.N. Rensen, Ingrid M. Jazet, Ko Willems van Dijk, Hildo J. Lamb, Maurice B. Bizino
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports, 9. NATURE PUBLISHING GROUP
Scientific Reports, 9
Scientific Reports
Scientific Reports, 9. NATURE PUBLISHING GROUP
Scientific Reports, 9
Scientific Reports
Cholesteryl ester transfer protein (CETP) is mainly expressed by Kupffer cells in the liver. A reduction of hepatic triglyceride content (HTGC) by pioglitazone or caloric restriction is accompanied by a decrease in circulating CETP. Since GLP-1 analo
Autor:
Maurice B, Bizino, Ingrid M, Jazet, Huub J, van Eyk, Patrick C N, Rensen, Petronella H, Geelhoed-Duijvestijn, Aan V, Kharagjitsingh, Elisabeth H M, Paiman, Johannes W, Smit, Hildebrandus J, Lamb
Publikováno v:
Acta diabetologicaReferences. 58(4)
Data on the effect of liraglutide on glycemic endpoints in people with T2DM using multiple daily insulin injections (MDI) are scarce, especially in the context of ethnicity.This is a secondary analysis of the placebo-controlled randomized clinical "M